☆ 4.7 Article

Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Medicine, General & Internal

Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer

Sarina K. K. Mueller et al.

Summary: Surgical resection is the preferred treatment for salivary gland cancer. For inoperable and metastatic disease, various systemic therapies are available. However, there is a need for more research and molecular analysis to improve treatment outcomes.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Oncology

Establishment of a patient-derived mucoepidermoid carcinoma cell line with the CRTC1-MAML2 fusion gene

Kazuma Noguchi et al.

Summary: Mucoepidermoid carcinoma (MEC) is the most common malignant tumor of the salivary glands. This study established a low-grade MEC cell line from a patient and found activation of the AREG-EGFR signaling pathway, which may contribute to tumor growth and survival. This cell line could potentially aid in the identification of new strategies for MEC treatment.

MOLECULAR AND CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among Patients

Yutaro Kondo et al.

Summary: The expression of PD-L1 is regulated by complex mechanisms. This study focused on the mechanisms of PD-L1 expression in OSCCs and found that EGF and IFN-gamma upregulate PD-L1 through different signaling pathways. Moreover, the phosphorylation pattern of related molecules in PD-L1-positive cells varied among different cases. These findings suggest that choosing the appropriate combination drugs for PD-1 blockade cancer treatment should consider the tissue environment and molecular alterations affecting PD-L1 expression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Oncology

Advances in the Treatment of Mucoepidermoid Carcinoma

Srikar Sama et al.

Summary: Mucoepidermoid carcinoma (MEC) is a common subtype of salivary neoplasms, but its low incidence poses challenges in clinical trials and treatment guideline development. Surgery is the most common approach for resectable tumors, but other options such as chemotherapy, radiotherapy, and immunotherapy are being investigated. Standardized treatment protocols and assessment of chromosomal and genetic abnormalities are necessary for effective management of MEC. Biomarker-driven research can greatly improve outcomes, especially in advanced cases.

WORLD JOURNAL OF ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Pembrolizumab as a first line therapy in a patient with extensive mucoepidermoid salivary gland carcinoma. A complete clinical, radiological and pathological response. A very specific case

Raed Farhat et al.

Summary: The use of pembrolizumab as a first line therapy showed promising results in a unique case of advanced high grade mucoepidermoid carcinoma of the parotid salivary gland, leading to downstaging of the tumor and successful surgical excision without major adverse effects. Further research is needed to explore the potential of pembrolizumab as a frontline treatment for these types of malignancies.

DISCOVER ONCOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma

Wei Ni et al.

Summary: This study identified the critical role of Notch signaling in maintaining MEC stem-like cells and tumor growth, and revealed a novel approach of co-targeting Notch and EGFR signaling as a potential effective anti-MEC treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Article Pathology

Pathologic grading of mucoepidermoid carcinomas of the salivary gland and its effect on clinicopathologic follow-up: an institutional experience

Khurram Shafique et al.

HUMAN PATHOLOGY (2020)

添加到收藏夹

Article Immunology

Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer

Eri Sugiyama et al.

SCIENCE IMMUNOLOGY (2020)

添加到收藏夹

Article Oncology

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

Aurelien Marabelle et al.

LANCET ONCOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Head and neck squamous cell carcinoma

Daniel E. Johnson et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

添加到收藏夹

Article Oncology

Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma

Andrew C. Birkeland et al.

ORAL ONCOLOGY (2017)

添加到收藏夹

Article Otorhinolaryngology

Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma

Rami E. Saade et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells

Z. Chen et al.

ONCOGENE (2014)

添加到收藏夹

Article Oncology

Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma

Kristy A. Warner et al.

ORAL ONCOLOGY (2013)

添加到收藏夹

Article Dentistry, Oral Surgery & Medicine

Salivary tumours

John W. Eveson

PERIODONTOLOGY 2000 (2011)

添加到收藏夹

Article Pathology

A Reappraisal of the MECT1/MAML2 Translocation in Salivary Mucoepidermoid Carcinomas

Raja R. Seethala et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)

添加到收藏夹

Review Oncology

Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer

William Pao et al.

NATURE REVIEWS CANCER (2010)

添加到收藏夹

Review Oncology

t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma

Iain D. O'Neill

ORAL ONCOLOGY (2009)

添加到收藏夹

Article Oncology

Herpes oncolytic therapy of salivary gland carcinomas

Vincent Reid et al.

INTERNATIONAL JOURNAL OF CANCER (2008)

添加到收藏夹

Article Oncology

CRTCI/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors:: Implications for histogenesis and biologic behavior

Yamilet Tirado et al.

GENES CHROMOSOMES & CANCER (2007)

添加到收藏夹

Article Oncology

Molecular classification of mucoepidermoid carcinomas -: Prognostic significance of the MECT1-MAML2 fusion oncogene

A Behboudi et al.

GENES CHROMOSOMES & CANCER (2006)

添加到收藏夹

Article Biochemistry & Molecular Biology

Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation

LZ Wu et al.

EMBO JOURNAL (2005)

添加到收藏夹

Review Dentistry, Oral Surgery & Medicine

Intraoral minor salivary gland neoplasms: Review of 213 cases

WY Yih et al.

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2005)

添加到收藏夹

Article Genetics & Heredity

t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway

G Tonon et al.

NATURE GENETICS (2003)

添加到收藏夹

Article Pathology

Mucoepidermoid carcinoma - A clinicopathologic study of 80 patients with special reference to histological grading

MS Brandwein et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.